Acumen Pharmaceuticals Inc (ABOS) showcases promising developments in Alzheimer's treatment and cost management, despite reporting a net loss for the quarter.

Non-hardware investments in artificial intelligence could surpass $1 trillion globally in the coming years, Goldman Sachs said, as companies pour money into data infrastructure, software and ...

After 12 weeks of travelling overseas, pensioners will see their supplement stop altogether. If they are moving overseas ...

Clicking on the wrong ad has seen some Aussies lose an immense amount of their retirement savings. The industry wants them ...

Ironically, a policy designed to reduce investor influence in the housing market could have the opposite effect on liquidity.

Bank of America just got even more bullish on CoreWeave (CRWV), spearheaded by the market’s insatiable demand for AI ...

Koonenberry Gold Ltd (ASX:KNB) has extended gold mineralisation at the Sunnyside Prospect within its Enmore Project in ...

Materials stocks advanced over 2% to lead gainers in midday trading on Tuesday amid a broadly lower market ahead of the ...

New Zealand shares ended lower on Tuesday as investors saw fading hopes of a US-Iran peace agreement. The S&P/NZX 50 Index fell 0.99% or 130.15 points to close at 13,080.33. US President Donald Trump ...

Australian shares declined on Tuesday as investors await the May 2026 Federal government budget in Australia, which is ...

Auravelle Metals Ltd (ASX:AUV) is preparing to start its next round of reverse circulation (RC) drilling at the Nuckulla Hill ...

Dalaroo Metals Ltd (ASX:DAL) has completed a large-scale systematic soil geochemistry program across the Gold Ridge Prospect ...